Cardiol Therapeutics (CRDL)

Technical Analysis Historical Data Financials News & Analysis

CRDL NEWS

What is HC Wainwright’s Forecast for CRDL Q2 Earnings? By MarketBeat - 4 weeks ago

Cardiol Therapeutics Inc. (NASDAQ:CRDL – Free Report) – HC Wainwright issued their Q2 2025 earnings per share (EPS) estimates for shares of Cardiol Therapeutics in a research note issued to investors… [+3096 chars]...

Read more
Cardiol Therapeutics (NASDAQ:CRDL) Now Covered by Analysts at HC Wainwright By MarketBeat - 1 month ago

HC Wainwright started coverage on shares of Cardiol Therapeutics (NASDAQ:CRDL – Free Report) in a research note issued to investors on Monday morning, MarketBeat.com reports. The firm issued a buy ra… [+2555 chars]...

Read more
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives $8.67 Consensus Price Target from Brokerages By MarketBeat - 1 week ago

Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL – Get Free Report) have been assigned an average rating of “Buy” from the five ratings firms that are covering the stock, MarketBeat.com reports. Thre… [+3185 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		215.92 3.89
1.83%
CVX 		148.37 0.39
0.26%
CAT 		397.86 -0.57
-0.14%
INTC 		22.49 0.61
2.79%
MSFT 		498.84 7.75
1.58%
DIS 		124 1.02
0.83%
DOW 		28.46 -0.27
-0.94%
CSCO 		69.37 0.78
1.14%
GS 		723.68 7.79
1.09%